NDA Group Releases Data Comparing FDA and EMA Ahead of Annual DIA EuroMeeting in Glasgow

Posted by on Mar 28, 2017 in NHS | 0 comments

Drop in US drug approvals but no similar trend is seen in EU Glasgow, United Kingdom (March 28, 2017) – NDA Group announced findings from their fourth annual comparison of drug approvals in Europe and the United States, ahead of this year’s DIA EuroMeeting in Glasgow. This year’s Status of New Drug Approvals report emphasises the need for a streamlined global development and commercialisation process across the world’s two biggest markets. The...

Read More

Artificial intelligence to help create automated virtual GPs to advise patients online in ground-breaking university partnership

Posted by on Mar 23, 2017 in Blog, NHS | 0 comments

Orbital Media, digital and social specialists, and the University of Essex have today announced they are joining forces to use artificial intelligence to save the NHS millions of pounds per year by creating automated online GPs to revolutionise the way patients are treated. In partnership with Innovate UK, the project will exploit Artificial Intelligence (AI) and Machine Learning technology to provide medically approved health advice to the...

Read More

Expert comment on protection for NHS whistleblowing

Posted by on Mar 20, 2017 in NHS | 0 comments

Paula Kathrens, an employment specialist at law firm Blake Morgan, said: “Today’s consultation is good news for NHS staff and ultimately good news for the NHS and the public it serves. The health sector has one of the highest instances of whistleblowing reporting and currently the law does not protect job applicants who have blown the whistle in a previous employment. This is one area where the UK whistleblowing legislation differs...

Read More

Cancer Research UK responds to NICE proposal of £20M impact test

Posted by on Mar 15, 2017 in Blog, NHS | 0 comments

Cancer Research UK is urging NICE to reconsider proposals to introduce a £20 million impact test on new drugs which include vital end-of-life medication. Presently the National Institute for Health and Care Excellence (NICE) decides which medicines are good value for money for NHS England. The new proposals are to have an extra affordability test which could mean that from next month NHS England will be able to delay drugs if the total cost to...

Read More

Forgotten Children: Chancellor’s Social Care Budget fails seriously ill children

Posted by on Mar 10, 2017 in Blog, NHS | 0 comments

Children’s palliative care charity Together for Short Lives is disappointed at the lack of support in the Spring Budget for the UK’s 49,000 children with life-limiting or life-threatening conditions. We believe that the Chancellor had a golden opportunity to transform the lives of these seriously ill children by addressing the postcode lottery in funding for children’s palliative care. It’s very disappointing and worrying that the...

Read More